Copyright
©The Author(s) 2016.
World J Radiol. Jan 28, 2016; 8(1): 21-49
Published online Jan 28, 2016. doi: 10.4329/wjr.v8.i1.21
Published online Jan 28, 2016. doi: 10.4329/wjr.v8.i1.21
Table 1 Estimates of apparent diffusion coefficient values reported in healthy human liver using a mono-exponential fit
Ref. | System | Field strength (T) | Sequence | TR/TE (ms/ms) | No. of patients/mean age (SD) (yr) | b-values (s/mm2) | Mean ADC (SD) (× 10-3 mm2/s) |
Müller et al[60], 1994 | Siemens | 1.5 | STEAM EPI, BH | 2BH/18 | 10 (7F, 3M)/24 | 2, 8, 22, 32, 57, 89, 176, 395 | 1.39 (0.16) |
Ichikawa et al[28], 1998 | Siemens Vision | 1.5 | SS SE EPI, BH, FS | NR/54 | 46 (14F, 32M)/58 | 1.6, 16, 55 | 2.28 (1.23) |
Yamada et al[24], 1999 | Siemens Vision | 1.5 | SS SE EPI, BH, FS | NR/123 | 47 | 0, 30, 300, 900, 1100 | 0.87 (0.26) |
Kim et al[29], 1999 | GE Signa | 1.5 | SS SE EPI, BH (6s), FS | NR/70 | P1: 6 (1F, 5M)/29 P2: 48 (18F, 30M)/57 | 3, 57, 192, 408, 517, 705, 846 | b < 850: P1: 1.05 (0.30) P2: 1.02 (0.25) b < 410: P1: 1.55 (0.37) P2: 1.16 (0.42) b < 100: P1: 4.80 (2.37) P2: 3.55 (1.75) |
Moteki et al[25], 2002 | Siemens Impact | 1.0 | Turbo FLASH, BH, FA = 12° | 8.8/4 | 46 | 0, 50.2, 295 | 1.11 (1.02), 12.3 (5.17) |
1Mürtz et al[32], 2002 | Philips Intera | 1.5 | SS EPI, RT, BHE, SPIR + four saturation slabs | (1) RT, 4HB/83 (2) 3000/83 | 12 (4F, 8M)/31 | 50, 300, 700, 1000, 1300 | (1) 0.92-0.96 (0.09-0.14) (2) 1.03-1.14 (0.22-0.40) |
Boulanger et al[155], 2003 | GE Signa | 1.5 | SS EPI, BH | 3000/52 | 10 (2F, 8M)/43.5 | 50, 100, 150, 200, 250 | 1.79 (0.25) |
Chow et al[55], 2003 | GE Signa | 1.5 | SS EPI | 3000/(46.9-57.5) | 12 (4F, 8M)/29 | 10, 300 | 1.697 (0.052) |
Taouli et al[47], 2003 | Philips Intera | 1.5 | SS EPI, BH, FS | (1) 2400/ 104 | 14 | (1) 0, 500 | (1) 1.83 (0.36) |
(2) 3106/ 104 | (2) 0, 134, 267, 400 | (2) 1.51 (0.49) | |||||
Taouli et al[39], 2004 | Philips Intera | 1.5 | SS EPI, FS | (1800-2400)/(63-83) | 10 (3F, 7M)/33 | 0, 500 | NPI: 1.60 (0.13) |
PI: 1.52 (0.15) | |||||||
DTI + PI: 1.51 (0.21) | |||||||
Deng et al[156], 2006 | Siemens Sonata | 1.5 | (1) SS SE EPI, BH | 2000/82 | 9 | 0, 502 | (1) 1.18 (0.14) |
(2) MS PROPELLER, FB, RT, FS + 2 saturation slabs | 2000/105 | (2) 1.39 (0.19) | |||||
Lewin et al[157], 2007 | Siemens Maestro | 1.5 | SS SE EPI, NC, FS | 1400/76 | 20 (9F, 11M)/31.4 (7) | 0, 200, 400, 800 | 1.44 (0.02) |
Taouli et al[158], 2007 | Siemens Avanto | 1.5 | SS EPI, BH, FS | 1300/(51-71) | 7 (2F, 5M)/32 | 0, 50, 300, 500, 700, 1000 | 1.66 (0.12) |
Luciani et al[159], 2008 | Siemens Avanto | 1.5 | RT | 1500/70 | 25 (13F, 12M)/48 (16) | 0, 200, 400, 800 | 1.39 (0.2) |
Bruegel et al[160], 2008 | Siemens Avanto | 1.5 | SS EPI, NC, BH, FS | NR/69 | 102 (46F, 56M)/61 | 50, 300, 600 | 1.24 (0.15) |
Braithwaite et al[49], 2009 | Siemens Trio | 3.0 | Stimulated echo EPI, FB, FS | 3200/76 | 20 (20M)/34.7 | 0, 400 | 2.4 (0.50) E |
2Saremi et al[161], 2011 | a. Siemens Avanto | a. 1.5 | SS SE EPI, FS | (1) 150/75 | 13 (2F, 11M)/46 (13) | 50, 400, 1000 | a. 0.86(0.2) |
b. Siemens Trio | b. 3.0 | (1) BH, no PI | (2) 144/72 | b. 0.83(0.2) | |||
(2) BH, PI | (3) 174/87 | ||||||
(3) FB, PI | |||||||
Watanabe et al[51], 2011 | Philips Achieva | 3.0 | SS EPI, BH | 2291/44 | 18 | 0, 500 | 1.36 (0.11) |
Bakan et al[162], 2012 | Siemens Avanto | 1.5 | SS SE EPI, FS | 4800/82 | 25 (11F, 14M)/39.8 (11.4) | 0, 500, 1000 | 1.75 (0.14) |
Miquel et al[34], 2012 | Philips Achieva | 1.5 | SS SE EPI, FB | (5300-5800)/62 | 10 (7F, 3M)/32.3 (4.6) | 100, 200, 500, 750, 1000 | V1: 1.05 (0.04) V2: 1.06 (0.07) |
3Andreou et al[163], 2013 | Siemens Avanto | 1.5 | SS SE EPI, NC, RT, FS | 5000/68 | 14 (7F, 7M)/59.7 | 0, 25, 50, 75, 100, 250, 500, 900 | 1.22 |
Corona-Villalobos et al[58], 2013 | Siemens Avanto | 1.5 | SS SE EPI, BH | (1) 3000/(69-79) | 100 (36F, 64M)/60.4 (14.3) | (1) 0, 750 | (1) 1.22 (0.15) |
(2) 2500/(76-95) | (2) 0, 50, 100, 200, 300, 450, 600, 750 | (2) 0.96 (0.08) | |||||
Klasen et al[63], 2013 | Siemens Avanto | 1.5 | SS EPI | (6825-6930)/(68-76) | 50 (30F, 20M)/55.1 | 50, 300, 600 | O1: 1.053 (0.124) |
O2: 1.088 (0.146) | |||||||
Larsen et al[48], 2013 | Philips Achieva | 3.0 | SS SE EPI, BHI, BHE, RT, FB, FS | (1600-2000)/71-72 | 10 (4F, 6M)/24 | 0, 150, 500, 750, 1000 | b = 0, 750: |
BHI: 1.52 (0.11) | |||||||
BHE: 1.54 (0.1) | |||||||
FB: 1.44 (0.11) | |||||||
RT: 1.48 (0.11) | |||||||
b = 150, 750: | |||||||
BHI: 0.81 (0.09) | |||||||
BHE: 0.83 (0.10) | |||||||
FB: 0.91 (0.08) | |||||||
RT: 0.92 (0.07) | |||||||
Penner et al[164], 2013 | Philips Intera | 1.5 | SS SE EPI, RT, SPIR | 1648/63 | 15 (12F, 3M)/44 (11) | 0, 50, 800 | 1.30 (0.11) |
Donati et al[56], 2014 | (1) Siemens Sonata | 1.5 | SS SE EPI, FB, FS | (5000-6225)/(36-76) | 10 (10M)/36.6 (7.7) | 0, 1000 | (1) LL: 1.207 (0.194) |
(2) Siemens Trio | 3.0 | RL: 1.026 (0.260) | |||||
(3) Philips Achieva | 1.5 | (2) LL: 1.132 (0.250) | |||||
(4) Philips Achieva | 3.0 | RL: 0.966 (0.187) | |||||
(5) GE Signa | 1.5 | (3) LL: 1.349 (0.178) | |||||
(6) GE Discovery | 3.0 | RL: 1.128 (0.127) | |||||
(4) LL: 1.097 (0.129) | |||||||
RL: 1.108 (0.110) | |||||||
(5) LL: 1.271 (0.133) | |||||||
RL: 1.151 (0.162) | |||||||
(6) LL: 1.524 (0.356) | |||||||
RL: 1.280 (0.372) | |||||||
Leporq et al[33], 2015 | GE Discovery | 3.0 | SE EPI, RT, FB, No FS | 2000/(48-55) | 25 (9F, 16M)/27.1 (4.5) | 0, 800 | RT: 1.65 (0.28) |
FB + (TE = 48): 1.63 (0.22) | |||||||
FB + (TE = 55): 1.57 (0.26) | |||||||
FB + WA: | |||||||
1.55 (0.24) | |||||||
Duran et al[165], 2015 | Philips Intera | 1.5 | SS EPI, FB, SPIR | 3448/63 | 53 (33F, 20M)/50 | 0, 150, 600 | 1.52 (0.32) |
Table 2 Estimates of apparent diffusion coefficient values reported in human kidney (renal parenchyma) using a mono-exponential fit
Ref. | System | Field strength (T) | Sequence | TR/TE (ms/ms) | No. of patients/mean age (SD) (yr) | b-values (s/mm2) | Mean ADC (SD) (× 10-3 mm2/s) |
Müller et al[60], 1994 | Siemens | 1.5 | STEAM EPI, BH | 2BH/18 | 10 (7F, 3M)/24 | 2, 8, 22, 32, 57, 89, 176, 395 | 3.54 (0.47) |
Kim et al[29], 1999 | GE Signa | 1.5 | SS SE EPI, BH (6s), FS | NR/70 | P1: 6 (1F, 5M)/29 P2: 48 (18F, 30M)/57 | 3, 57, 192, 408, 517, 705, 846 | b < 850: P1: 1.79 (0.27) P2: 1.92 (0.32) b < 410: P1: 1.79 (0.49) P2: 2.14 (0.44) b < 100: P1: 2.98 (3.01) P2: 3.73 (1.94) |
Yamada et al[24], 1999 | Siemens Vision | 1.5 | SS SE EPI, BH, FS | NR/123 | 78 | 0, 30, 300, 900, 1100 | 1.55 (0.27) |
Namimoto et al[30], 1999 | Siemens Vision | 1.5 | SS SE EPI, BH | NR/123 | 16 | 30, 300 | M: 2.84 (0.72) |
C: 2.55 (0.62) | |||||||
Ries et al[41], 2001 | Philips | 1.5 | (1) SS EPI, BH | BH/86 | 10 | 0, 195, 390 | a. C: 2.80 (0.32) |
(2) MS EPI, BH | BH/94 | M: 2.30 (0.42) | |||||
b. C: 2.89 (0.28) | |||||||
M: 2.18 (0.36) | |||||||
1Mürtz et al[32], 2002 | Philips Intera | 1.5 | SS EPI, RT, BHE, SPIR + four saturation slabs | (1) RT, 4HB/83 (2) 3000/83 | 12 (4F, 8M)/31 | 50, 300, 700, 1000, 1300 | C: (1) 1.63-1.66 (0.09-0.14) (2) 1.67-1.81 (0.22-0.26) |
Chow et al[55], 2003 | GE Signa | 1.5 | SS EPI | 3000/(46.9-57.5) | 12 (4F, 8M)/29 | 10, 300 | M: 2.091 (0.055) |
C: 2.58 (0.053) | |||||||
Thoeny et al[31], 2005 | Siemens Sonata | 1.5 | SS EPI, FB, FS + two saturation slabs | 3200/71 | 18 (5F, 13M)/27 | 0, 50, 100, 150, 200, 250, 300, 500, 750, 1000 | b ≤ 1000: M: 1.87 (0.08) C: 2.03 (0.09) b > 300: M: 1.50 (0.12) C: 1.67 (0.11) b < 150: M: 3.76 (0.55) C: 3.72 (0.45) |
Yoshikawa et al[57], 2006 | Philips Intera | 1.5 | SS EPI, BH, SPIR | 1500/66 | (1) 145 | 0, 600 | (1) R, 2.67 (0.29) |
(2) 144 | (2) L, 2.60 (0.32) | ||||||
Kilickesmez et al[64], 2008 | Siemens Avanto | 1.5 | SS EPI, FB, FS | 4900/93 | 50 (29F, 21M)/38.9 | 0, 500, 1000 | M: 1.94 (0.18) |
C: 2.08 (0.22) | |||||||
2Saremi et al[161], 2011 | a. Siemens Avanto | a. 1.5 | SS SE EPI, FS | (1) 150/75 | 13 (2F, 11M)/46 (13) | 50, 400, 1000 | a. 1.8 (0.1) |
b. Siemens Trio | b. 3.0 | (1) BH, no PI | (2) 144/72 | b. 1.8 (0.1) | |||
(2) BH, PI | (3) 174/87 | ||||||
(3) FB, PI | |||||||
Miquel et al[34], 2012 | Philips Achieva | 1.5 | SS SE EPI, FB | (5300-5800)/62 | 10 (7F, 3M)/32.3 (4.6) | 100, 200, 500, 750, 1000 | V1: 1.76 (0.08) |
V2: 1.76 (0.10) | |||||||
Corona-Villalobos et al[58], 2013 | Siemens Avanto | 1.5 | SS SE EPI, BH | (1) 3000/(69-79) | 100 (36F, 64M)/60.4 (14.3) | (1) 0, 750 | (1) R, 2.07 (0.18) |
(2) 2500/(76-95) | (2) 0, 50, 100, | L, 2.08 (0.19) | |||||
200, 300, 450, | (2) R, 1.79 (0.17) | ||||||
600, 750 | L, 1.78 (0.16) | ||||||
Donati et al[56], 2014 | (1) Siemens Sonata | 1.5 | SS SE EPI, FB, FS | (5000-6225)/(36-76) | 10 (10M)/36.6 (7.7) | 0, 1000 | (1) C: 1.92 (0.169) |
(2) Siemens Trio | M: 1.90 (0.137) | ||||||
(3) Philips Achieva | 3.0 | (2) C: 1.86 (0.132) | |||||
(4) Philips Achieva | M: 1.80 (0.093) | ||||||
(5) GE Signa | 1.5 | (3) C: 1.95 (0.176) | |||||
(6) GE Discovery | M: 1.93 (0.11) | ||||||
3.0 | (4) C: 1.94 (0.132) | ||||||
M: 1.90 (0.11) | |||||||
1.5 | (5) C: 1.95 (0.156) | ||||||
3.0 | M: 1.94 (0.143) | ||||||
(6) C: 2.05 (0.194) | |||||||
M: 1.93 (0.147) | |||||||
Sulkowska et al[166], 2015 | Philips Ingenia | 1.5 | SS EPI | NR/71 | 50 (28F, 22M)/39 (12) | (1) 0, 50, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750 | (1) C: 2.26 (0.2) M: 2.21 (0.17) |
(2) 0, 10, 20, 40, 60, 150, 300, 500, 700, 900 | (2) C: 2.13 (0.16) M: 2.06 (0.2) |
Table 3 Estimates of apparent diffusion coefficient values reported in human spleen using a mono-exponential fit
Ref. | System | Field strength (t) | Sequence | TR/TE (ms/ms) | No. of patients/mean age (sd) (yr) | b-values (s/mm2) | Mean ADC (sd) (× 10-3 mm2/s) |
Müller et al[60], 1994 | Siemens | 1.5 | STEAM EPI, BH | 2BH/18 | 10 (7F, 3M)/24 | 2, 8, 22, 32, 57, 89, 176, 395 | 0.95 (0.15) |
Yamada et al[24], 1999 | Siemens Vision | 1.5 | SS SE EPI, BH, FS | NR/123 | 76 | 0, 30, 300, 900, 1100 | 0.88 (0.33) |
Kim et al[29], 1999 | GE Signa | 1.5 | SS SE EPI, BH (6sec), FS | NR/70 | P1: 6 (1F, 5M)/29 P2: 48 (18F, 30M)/57 | 3, 57, 192, 408, 517, 705, 846 | b < 850: P1: 0.93 (0.30) P2: 0.80 (0.34) b < 410: P1: 0.85 (0.25) P2: 0.99 (0.54) b < 100: P1: 2.17 (3.28) P2: 2.81 (1.93) |
1Mürtz et al[32], 2002 | Philips Intera | 1.5 | SS EPI, RT, BHE, SPIR + four saturation slabs | (1) RT, 4HB/83 (2) 3000/83 | 12 (4F, 8M)/31 | 50, 300, 700, 1000, 1300 | (1) 0.59-0.63 (0.04-0.06) (2) 0.73-0.85 (0.25-0.36) |
Chow et al[55], 2003 | GE Signa | 1.5 | SS EPI | 3000/(46.9-57.5) | 12 (4F, 8M)/29 | 10, 300 | 1.047 (0.082) |
Yoshikawa et al[57], 2006 | Philips Intera | 1.5 | SS EPI, BH, SPIR | 1500/66 | 185 | 0, 600 | 1.26 (0.23) |
Bruegel et al[160], 2008 | Siemens Avanto | 1.5 | SS EPI, NC, BH, FS | NR/69 | 96 | 50, 300, 600 | 0.82 (0.11) |
Kiliçkesmez[64], 2008 | Siemens Avanto | 1.5 | SS EPI, FB, FS | 4900/93 | 50 (29F, 21M)/38.9 | 0, 500, 1000 | 1.28 (0.38) |
Braithwaite et al[49], 2009 | Siemens Trio | 3.0 | Stimulated Echo EPI, FB, FS | 3200/76 | 20 (20M)/34.7 | 0, 400 | 1.28 (0.39) |
2Saremi et al[161], 2011 | a. SiemensAvanto | a. 1.5 | SS SE EPI, FS | (1) 150/75 | 13 (2F, 11M)/46 (13) | 50, 400, 1000 | a. 0.7 (0.05) |
b. SiemensTrio | b. 3.0 | (1) BH, no PI | (2) 144/72 | b. 0.65 (0.08) | |||
(2) BH, PI | (3) 174/87 | ||||||
(3) FB, PI | |||||||
Miquel et al[34], 2012 | Philips Achieva | 1.5 | SS SE EPI, FB | (5300-5800)/62 | 10 (7F, 3M)/32.3 (4.6) | 100, 200, 500, 750, 1000 | V1: 0.81 (0.06) V2: 0.82 (0.07) |
Corona-Villalobos et al[58], 2013 | Siemens Avanto | 1.5 | SS SE EPI, BH | (1) 3000/(69-79) | 100 (36F, 64M)/60.4 (14.3) | (1) 0, 750 | (1) 0.90 (0.10) |
(2) 2500/(76-95) | (2) 0, 50, 100, | (2) 0.80 (0.08) | |||||
200, 300, 450, | |||||||
600, 750 | |||||||
Klasen et al[63], 2013 | Siemens Avanto | 1.5 | SS EPI | (6825-6930)/(68-76) | 50 (30F, 20M)/55.1 | 50, 300, 600 | O1: 0.774 (0.061) |
O2: 0.805 (0.081) | |||||||
Donati et al[56], 2014 | (1) Siemens Sonata | 1.5 | SS SE EPI, FB, FS | (5000-6225)/(36-76) | 10 (10M)/36.6 (7.7) | 0, 1000 | (1) 0.863 (0.092) |
(2) Siemens Trio | 3.0 | (2) 0.775 (0.069) | |||||
(3) Philips Achieva | 1.5 | (3) 0.876 (0.153) | |||||
(4) Philips Achieva | 3.0 | (4) 0.851 (0.080) | |||||
(5) GE Signa | 1.5 | (5) 0.855 (0.138) | |||||
(6) GE Discovery | 3.0 | (6) 0.888 (0.214) |
Table 4 Estimates of apparent diffusion coefficient values reported in human pancreatic body using a mono-exponential fit
Ref. | System | Field strength (T) | Sequence | TR/TE (ms/ms) | No. of Patients/mean age (SD) (year) | b-values (s/mm2) | Mean ADC (SD) (× 10-3 mm2/s) |
Yamada et al[24], 1999 | Siemens Vision | 1.5 | SS SE EPI, BH, FS | NR/123 | 78 | 0, 30, 300, 900, 1100 | 1.02 (0.28) |
Chow et al[55], 2003 | GE Signa | 1.5 | SS EPI | 3000/(46.9-57.5) | 12 (4F, 8M)/29 | 10, 300 | 2.605 (0.168) |
Deng et al[156], 2006 | Siemens Sonata | 1.5 | (1) SS SE EPI, BH | 2000/82 | 9 | 0, 502 | (1) 1.88 (0.27) |
(2) MS PROPELLER, FB, RT, FS + two saturation slabs | 2000/105 | (2) 2.14 (0.31) | |||||
Yoshikawa et al[57], 2006 | Philips Intera | 1.5 | SS EPI, BH, SPIR | 1500/66 | 124 | 0, 600 | 1.81 (0.41) |
Kiliçkesmez et al[64], 2008 | Siemens Avanto | 1.5 | SS EPI,FB, FS | 4900/93 | 50 (29F, 21M)/38.9 | 0, 500, 1000 | 1.68 (0.26) |
Braithwaite et al[49], 2009 | Siemens | 3.0 | Stimulated Echo EPI, FB, FS | 3200/76 | 20 (20M)/34.7 | 0, 400 | 2.63 (0.72) |
Fattahi et al[65], 2009 | Philips Intera | 1.5 | SS EPI, BH | 1500/66 | 14 (11F, 3M)/46.1 | 0, 600 | 1.78 (0.07) |
1Saremi et al[161], 2011 | a. Siemens Avanto | a. 1.5 | SS SE EPI, FS | (1) 150/75 | 13 (2F, 11M)/46 (13) | 50, 400, 1000 | a. 1.07 (0.1) |
b. Siemens Trio | b. 3.0 | 1. BH, no PI | (2) 144/72 | b. 1.08 (0.1) | |||
2. BH, PI | (3) 174/87 | ||||||
3. FB, PI | |||||||
Thomas et al[167], 2012 | Philips Achieva | 1.5 | SS EPI, FB, RT, FS | 8000/90 | 38 (24F, 14M)/56 | 0, 800 | 1.77 (0.32) |
Corona-Villalobos et al[58], 2013 | Siemens Avanto | 1.5 | SS SE EPI, BH | (1) 3000/(69-79) | 100 (36F, 64M)/60.4 (14.3) | (1) 0, 750 | (1) 1.70 (0.22) |
(2) 2500/(76-95) | (2) 0, 50, 100, | (2) 1.26 (0.16) | |||||
200, 300, 450, | |||||||
600, 750 | |||||||
Ma et al[168], 2014 | GE Signa | 3.0 | SS SE EPI, BH, RT, FB, SPIR | (2275-5454)/58.8 | 21 (11F, 10M)/28.3 (3.6) | 0, 500 | BH: 1.57 (0.26) |
RT: 1.75 (0.28) | |||||||
FB: 1.71 (0.28) | |||||||
Donati et al[56], 2014 | (1) Siemens Sonata | 1.5 | SS SE EPI, FB, FS | (5000-6225)/(36-76) | 10 (10M)/36.6 (7.7) | 0, 1000 | (1) 1.427 (0.165) |
(2) Siemens Trio | 3.0 | (2) 1.418 (0.189) | |||||
(3) Philips Achieva | 1.5 | (3) 1.427 (0.212) | |||||
(4) Philips Achieva | 3.0 | (4) 1.371 (0.193) | |||||
(5) GE Signa | 1.5 | (5) 1.496 (0.220) | |||||
(6) GE Discovery | 3.0 | (6) 1.621 (0.283) | |||||
Ma et al[153], 2015 | GE Signa | 3.0 | SS EPI | 6000/58.6 | 22 (13M)/63.7 (6.8) | 0, 600 | VOI: 1.44 (0.11) |
ROI: 1.40 (0.14) |
Table 5 Estimates of apparent diffusion coefficient values reported in human gallbladder using a mono-exponential fit
Ref. | System | Field strength (T) | Sequence | TR/TE (ms/ms) | No. of patients/mean age (SD) (yr) | b-values (s/mm2) | Mean ADC (SD) (× 10-3 mm2/s) |
Yamada et al[24], 1999 | Siemens Vision | 1.5 | SS SE EPI, BH, FS | NR/123 | 62 | 0, 30, 300, 900, 1100 | 2.81 (0.36) |
Yoshikawa et al[57], 2006 | Philips Intera | 1.5 | SS SE EPI, BH, SPIR | 1500/66 | 151 | 0, 600 | 3.50 (0.51) |
1Saremi et al[161], 2011 | a. SiemensAvanto b. SiemensTrio | a. 1.5 b. 3.0 | SS SE EPI, FS (1) BH, no PI (2) BH, PI (3) FB, PI | (1) 150/75 (2) 144/72 (3) 174/87 | 13 (2F, 11M)/46 (13) | 50, 400, 1000 | a. 2.6 (0.4) b. 2.6 (0.3) |
Miquel et al[34], 2012 | Philips Achieva | 1.5 | SS SE EPI, FB | (5300-5800)/62 | 10 (7F, 3M)/32.3 (4.6) | 100, 200, 500, 750, 1000 | V1: 2.93 (0.20) V2: 2.91 (0.21) |
Corona-Villalobos et al[58], 2013 | Siemens Avanto | 1.5 | SS SE EPI, BH | (1) 3000/(69-79) (2) 2500/(76-95) | 100 (36F, 64M)/60.4 (14.3) | (1) 0, 750 (2) 0, 50, 100, 200, 300, 450, 600, 750 | (1) 3.01 (0.33) (2) 2.74 (0.37) |
Donati et al[56], 2014 | (1) Siemens Sonata (2) Siemens Trio | 1.5 3.0 | SS SE EPI, FB, FS | (5000-6225)/(36-76) | 10 (10M)/36.6 (7.7) | 0, 1000 | (1) 2.585 (0.354) (2) 2.506 (0.223) |
(3) Philips Achieva | 1.5 | (3) 2.657 (0.229) | |||||
(4) Philips Achieva | 3.0 | (4) 2.718 (0.327) | |||||
(5) GE Signa | 1.5 | (5) 2.670 (0.312) | |||||
(6) GE Discovery | 3.0 | (6) 2.785 (0.477) |
Table 6 Estimates of apparent diffusion coefficient values reported in human prostate using a mono-exponential fit
Ref. | System | Field strength (T) | Sequence | TR/TE (ms/ms) | No. of patients/mean age (SD) | b-values (s/mm2) | Mean ADC (SD) (× 10-3 mm2/s) |
1Gibbs et al[77], 2001 | GE | 1.5 | SS SE EPI | 4000/110 | 8/29 | 0, 720 | CG: 1.17 (0.18) |
PZ: 1.25 (0.23) | |||||||
Issa[169], 2002 | GE | 1.5 | SS SE EPI | 4000/120 | 7/29 | 64, 144, 257, 401, 578, 786 | CG: 1.63 (0.30) PZ: 1.91 (0.46) |
Sato et al[79], 2005 | Siemens Symphony | 1.5 | SS SE EPI | 2700/96 | 6 | 0, 300, 600 | CG: 1.68 (0.26) PZ: 1.93 (0.24) |
Pickles et al[170], 2006 | GE Signa | 3.0 | SS SE EPI | 4000/65.7 | 9/32 | 0, 500 | CG: 1.27 (0.14) |
PZ: 1.60 (0.25) | |||||||
Kumar et al[78], 2006 | Siemens Avanto | 1.5 | SS SE EPI | 3000/96 | 7/31.4 (3.6) | 0, 250, 500, 750, 1000 | CG: 0.9 (0.1) PZ: 1.5 (0.2) |
Gibbs et al[171], 2007 | GE Excite | 3.0 | SS SE EPI | 4000/65.7 | 8/35 | 0, 500 | CG: 1.212, 1.263 |
PZ: 1.562, 1.633 | |||||||
Ren et al[172], 2008 | Philips Intera | 1.5 | SS SE EPI | 3000/63 | 16/37.9 | 0, 500 | CG: 1.352 (0.052) |
PZ: 1.829 (0.071) | |||||||
Kozlowski et al[76], 2008 | GE Signa | 1.5 | (1) SS FSE | (1) 8000/87.5 | (1) 14 | 0, 600 | (1) CG: 1.373 (0.179) |
(2) SS EPI | (2) 8000/87.5 | (2) 15 | PZ: 1.573 (0.270) | ||||
(2) CG: 1.518 (0.126) | |||||||
PZ: 1.992 (0.208) | |||||||
Tamada et al[173], 2008 | GE Signa | 1.5 | SS SE EPI | 5500/67.7 | 114/55 (1) 20 ≤ age ≤ 39 (n = 11) (2) 40 ≤ age ≤ 59 (n = 62) (3) 60 ≤ age ≤ 89 (n = 41) | 0, 1000 | (1) CG: 1.22 (0.10) PZ: 1.37 (0.18) (2) CG: 1.27 (0.12) PZ: 1.63 (0.26) (3) CG: 1.27 (0.12) PZ: 1.74 (0.25) |
Riches et al[27], 2009 | Philips Intera | 1.5 | SS SE EPI | 2500/69 | 50/66 (6) | 0, 800 | CG: 1.72 (0.35) |
PZ: 1.66 (0.34) | |||||||
Liu et al[174], 2013 | GE Signa | 3.0 | SS SE EPI | 4000/71.9 | 102 | 0, 1000 | n = 69, |
CG: 1.36 (0.12) | |||||||
n = 74, | |||||||
PZ: 1.69 (0.28) | |||||||
Emad-Eldin et al[74], 2014 | Philips Intera | 1.5 | SS SE EPI | 3600/110 | 12 | 0, 500, 800 | CG: 1.469 (0.239) |
PZ: 1.839 (0.233) | |||||||
4Peng et al[175], 2014 | Philips Achieva | 1.5 | SS SE EPI, FB | (1) (2948-8191)/(71-79) (2) (3854-8616)/(83-85) | (1) 26/61.1 (7.2) (2) 25/62.0 (6.4) | (1) 0, 1000 (2) 0, 50, 200, 1500, 2000 | PZ: (1) 1.75 (0.3) E (2) 1.33 (0.1) E |
Table 7 Estimates of apparent diffusion coefficient values reported in human Uterus (endometrium, myometrium and cervix) using a mono-exponential fit
Ref. | System | Field strength (T) | Sequence | TR/TE (ms/ms) | No. of patients/mean age (SD) | b-values (s/mm2) | Mean ADC (SD) (× 10-3 mm2/s) |
Naganawa et al[99], 2005 | Siemens Symphony | 1.5 | SS SE EPI | 2500/96 | 10/46.6 | 0, 300, 600 | Cervix, 1.79 (0.24) |
Tamai et al[88], 2007 | Siemens Symphony | 1.5 | SS SE EPI, FS | 4400/(74-99) | 12/49 | 0, 500, 100 | Endometrium, 1.53 (0.10) |
Zhang et al[176], 2007 | Philips Intera | 1.5 | SS SE EPI | 6800/70 | (9 + 7V)/34 median | 0, 800 | Cervix, 1.71 (0.14) |
McVeigh et al[91], 2008 | GE Signa | 1.5 | SS SE EPI | 4000/68 | 30/47 | 0, 600 | Cervix n = 26, 2.09 (0.46) |
Shen et al[92], 2008 | GE Excite | 1.5 | SS SE EPI | 8000/83 | 7/45.2 | 0, 500, 800, 1000 | Endometrium, 1.277 (0.219) |
Fujii et al[177], 2008 | Siemens Symphony | 1.5 | SS SE EPI, STIR FS, FB | (9500-9800)/(73-78) | 26/53 | 0, 1000 | Endometrium n = 25, 1.44 (0.34) |
Tamai et al[89], 2008 | Siemens Symphony | 1.5 | SS SE EPI, FS | (2700-4400)/(78-90) | 43/48 | 0, 500, 1000 | Myometrium, 1.62 (0.11) |
Inada et al[178], 2009 | GE Signa | 1.5 | SS SE EPI, FB | (3400-7500)/68 | 31/44.9 (12.7) | 0, 800 | Endometrium, 1.52 (0.20) |
Myometrium, 1.53 (0.25) | |||||||
Liu et al[179], 2009 | GE Excite | 1.5 | SS EPI | 4000/58.5 | 57 | 0, 1000 | Cervix, 1.50 (0.16) |
Payne et al[180], 2010 | Philips Intera | 1.5 | SS SE EPI | 4500/80 | 62/38 | 0, 100, 300, 500, 800 | Cervix n = 43, 1.769 (0.239) |
Chen et al[98], 2010 | Philips Intera | 1.5 | SS SE EPI, STIR FS | 6800/70 | 20/34.4 | 0, 800 | Cervix, 1.593 (0.151) |
Cao et al[87], 2012 | GE Signa | 1.5 | SS SE EPI, FB | NR/NR | 64/55.4 | 0, 1000 | Endometrium, 1.267 (0.221) |
Myometrium, 1.496 (0.196) | |||||||
Junctional zone, 1.126 (0.190) | |||||||
Kuang et al[90], 2013 | Siemens Trio | 3.0 | SS SE EPI, FS | AX: 7000/71, | 67 | (1) 0, 600 | Cervix, (1) 1.55 (0.28) |
SAG: 1800/76 | (2) 0, 1000 | (2) 1.41 (0.10) |
Table 8 Estimates of apparent diffusion coefficient values reported in the normal fibroglandular breast tissue using a mono-exponential fit
Ref. | System | Field strength (T) | Sequence | TR/TE (ms/ms) | No. of patients/mean age (SD) | b-values (s/mm2) | Mean ADC (SD) (× 10-3 mm2/s) |
Englander et al[181], 1997 | GE Signa | 1.5 | SE | (2 or 3)HB/100 | 4/32 (2.6) | 12.48, 611.31, 199.61, 449.12, 77.97, 311.89, 112.28 | 1.64 (0.19) |
Partridge et al[17], 2001 | GE Signa | 1.5 | SS FSE | 8000/86 | 8/27 | 0, 578 | n = 6, W1: 1.72 (0.23) W2: 1.61 (0.22) W3: 1.66 (0.17) W4: 1.75 (0.17) |
Sinha et al[105], 2002 | GE Signa | 1.5 | SS EPI | 5000/72 | 16 | 0, 269, 537, 806, 1074 | 2.37 (0.27) |
Woodhamset al[106], 2005 | GE Signa | 1.5 | SS SE EPI | 5000/61.8 | 190/53 | 0, 750, 1000 | 2.09 (0.27) |
Park et al[182], 2007 | GE Signa | 1.5 | SS EPI | 6000/75 | 41/53.1 | 0, 1000 | 1.51 (0.29) |
Yoshikawa et al[107], 2008 | Philips Intera | 1.5 | SS SE EPI | 6238/90 | 27 | 0, 200, 400, 600, 800 | 1.96 (0.21) |
Kim et al[119], 2009 | GE Signa | 1.5 | SS SE EPI | 6000/75 | 67/54 | 0, 1000 | 1.59 (0.27) |
Baron et al[114], 2010 | Siemens Avanto | 1.5 | SS SE EPI, (1) FS (2) STIR (3) SPAIR (4) WaterExcitation | 3000/93 | 7/26.6 | 0, 20, 40, 60, 80, 100, 150, 200, 300, 400, 500, 600 | (1) 1.99 (2) 2.02 (3) 2.03 (4) 2.06 overall 2.03 (0.03) |
Partridge et al[44], 2010 | GE Signa | 1.5 | SS SE EPI | 7 s/71.5 | 12/36 (median) | 0, 600, 1000 | 1.95 (0.24) |
O’Flynn et al[109], 2012 | Philips Achieva | 3.0 | SS SE EPI, SPAIR, SSGR | 3771/67 | 31/45.9 13 PRM/36.6 18 PM/55.2 | (1) 0, 100, 150, 200, 350, 700, 1200 (2) 100, 150, 200, 350, 700, 1200 | PRM, (1) 1.84 (0.26) (2) 1.77 (0.26) PM, (1) 1.46 (0.3) (2) 1.33 (0.3) |
Tagliafico et al[183], 2012 | GE Signa | 3.0 | SS EPI | 16675/NR | 60/57 (median) | 0, 1000 | 1.92 (0.30) |
AlRashidi et al[108], 2012 | Philips Achieva | 3.0 | SS SE EPI, SPAIR | 9543/50 | 26 | 0, 50, 150, 800 | MC, W1: 2.18 (0.38) W2: 2.20 (0.39) W3: 2.22 (0.38) W4: 2.22 (0.33) |
McDonald et al[184], 2014 | Philips Achieva | 3.0 | SS SE EPI | 5336/61 | 103/47 (11) | 0, 800 | 1.62 (0.30) |
Table 9 Estimates of apparent diffusion coefficient values of cancer vs normal tissue/benign disease reported in selected studies on different anatomical regions using a mono-exponential fit
Ref. | Anatomical region | Journal | Tumour and tissue | No. of subjects | b-values (s/mm2) | Mean ADC (SD) (× 10-3 mm2/s) |
Kim et al[29], 1999 | Liver | AJR | Malignant Normal liver | 49 48 | 3, 57, 192, 408, 517, 705, 846 | 1.01 (0.38) 1.92 (0.32) |
1Taouli et al[47], 2003 | Liver | Radiology | Metastatic lesions | 15 | (1) 0, 500 | (1) Lesions 0.94 (0.60) |
Normal liver | 14 | (2) 0, 134, 267, 400 | Normal 1.83 (0.36) | |||
(2) Lesions 0.85 (0.51) | ||||||
Normal 1.51 (0.49) | ||||||
Sato et al[79], 2005 | Prostate | JMRI | Prostate cancer | 23 | 0, 300, 600 | 1.11 (0.41) |
Normal prostate | 23 | 1.68 (0.40) | ||||
Naganawa et al[99], 2005 | Cervix | European | Cervical cancer | 12 | 0, 300, 600 | 1.09 (0.20) |
Radiology | Normal cervix | 10 | 1.79 (0.24) | |||
McVeigh et al[91], 2008 | Cervix | European | Cervical cancer | 47 | 0, 600 | 1.09 (0.20) |
Radiology | Normal cervix | 26 | 2.09 (0.46) | |||
Yoshikawa et al[107], 2008 | Breast | RadiationMedicine | IDC NIDC Normal breast | 24 3 27 | 0, 200, 400, 600, 800 | 1.07 (0.19) 1.42(0.17) 1.96(0.21) |
Kim et al[119], 2009 | Breast | JMRI | Breast cancer | 62 | 0, 1000 | 1.09 (0.27) |
Normal breast | 67 | 1.59 (0.27) | ||||
Riches et al[27], 2009 | Prostate | NMR in | Prostate cancer | 43 | 0, 800 | 1.33 (0.52) |
Biomedicine | Central gland | 50 | 1.72 (0.35) | |||
Peripheral zone | 50 | 1.66 (0.34) | ||||
Fattahi et al[65], 2009 | Pancreas | JMRI | Pancreatic cancer | 10 | 0, 600 | 1.46 (0.18) |
Normal pancreas | 14 | 1.78 (0.07) | ||||
Sugita et al[185], 2009 | Gallbladder | EuropeanRadiology | Gallbladder carcinoma | 15 | 0, 1000 | 1.28 (0.41) |
Gallbladder disease | 14 | 1.92 (0.21) | ||||
Taouli et al[186], 2009 | Kidney | Radiology | RCC | 64 (28 RCC) | 0, 400, 800 | 1.41 (0.61) |
Benign lesions | 64 (81 benign lesions) | 2.23 (0.87) | ||||
Wang et al[187], 2010 | Kidney | Radiology | RCC | 83 | (1) 0, 500 | (1) RCC 1.849 (0.399) |
RP | (2) 0, 800 | RP 2.455 (0.238) | ||||
(2) RCC 1.698 (0.323) | ||||||
RP 2.303 (0.172) | ||||||
Cao et al[87], 2012 | Uterus | European Journal of Radiology | Endometrial carcinoma | 13 | 0, 1000 | 1.011 (0.102) |
Normal endometrium | 64 | 1.267 (0.221) | ||||
Ogawa et al[188], 2012 | Gallbladder | Journal of Gastroenterology | Gallbladder carcinoma | 36 | 0, 1000 | 1.83 (0.69) |
Gallbladder disease | 117 | 2.60 (0.54) |
- Citation: Jafar MM, Parsai A, Miquel ME. Diffusion-weighted magnetic resonance imaging in cancer: Reported apparent diffusion coefficients, in-vitro and in-vivo reproducibility. World J Radiol 2016; 8(1): 21-49
- URL: https://www.wjgnet.com/1949-8470/full/v8/i1/21.htm
- DOI: https://dx.doi.org/10.4329/wjr.v8.i1.21